Pulmonology
Hospital Mortality Lower for Patients Treated by Female Physicians
Benefit of receiving treatment from female physicians larger for female than male patients
Alecensa Approved as First and Only ALK Inhibitor for Non-Small Cell Lung Cancer
Drug approved for patients with ALK-positive, early-stage cancer who undergo surgery to remove their tumor
RSV Burden in Children Under 5 Increased in 2021 and 2022 Versus 2015-2019
Children aged 24 to 59 months were 4.86 times as likely to be hospitalized in 2022 versus 2015 to 2019
Hypoglossal Nerve Stimulation Aids Obstructive Sleep Apnea
Higher body mass index, supine sleeping position may decrease therapeutic response
Eli Lilly Says Zepbound Can Ease Obstructive Sleep Apnea
Studies revealed that the medication reduced sleep apnea severity by nearly two-thirds
Midlife Mortality Higher in U.S. Than Other High-Income Countries
Not to the extent of the United States, but midlife deaths are worsening in the United Kingdom as well
FDA Adds Fasenra Indication for Severe Asthma in Children
Indication is for add-on maintenance treatment of children aged 6 to 11 years with severe eosinophilic asthma
Acute Cardiac Event Reported in 22.4 Percent of Seniors Hospitalized With RSV
Risk for experiencing acute cardiac event higher for adults with underlying cardiovascular disease
SARS-CoV-2 Positivity Not Linked to New Asthma Diagnosis in Children
Black race, food allergies, allergic rhinitis significantly associated with new diagnosis of asthma
Adjuvant Alectinib Improves Disease-Free Survival in Lung Cancer
Findings seen among patients with resected ALK-positive non-small cell lung cancer
